InspireMD (NSPR) Preferred Stock Liabilities (2017 - 2018)
InspireMD's (NSPR) quarterly Preferred Stock Liabilities came in at $2.3 million in Q2 2018, up 27.26% quarter-over-quarter from $1.8 million in Q1 2018.
InspireMD (NSPR) Preferred Stock Liabilities (2017 - 2018) Analysis & Trends
InspireMD's Preferred Stock Liabilities history runs 2 years deep, the most recent figure standing at $2.3 million for Q2 2018.
- On a quarterly basis, Preferred Stock Liabilities changed N/A year-over-year to $2.3 million in Q2 2018; TTM through Jun 2018 was $2.3 million, a N/A change from a year earlier, with the FY2017 full-year figure at $274000.0, changed N/A from the prior year.
- Preferred Stock Liabilities grew to $2.3 million in Q2 2018 per NSPR's latest filing, from $1.8 million in the prior quarter.
- Across five years, Preferred Stock Liabilities topped out at $2.3 million in Q2 2018 and bottomed at $274000.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InspireMD | 2,073.45 | -54.21 Mn | 1.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 2.26 Mn |
| Mar 31, 2018 | 1.78 Mn |
| Dec 31, 2017 | 274,000.00 |